Mark Klein
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 19
- Cancer-related Molecular Pathways 6
-
- Chemical Synthesis and Analysis 3
- Co-authors
- Berent J. Prakken (12 shared papers)Wietse Kuis (5 shared papers)Wilco de Jager (7 shared papers)Sebastiaan J. Vastert (6 shared papers)Salvatore Albani (5 shared papers)Lucy R. Wedderburn (3 shared papers)Nico Wulffraat (5 shared papers)Hemlata Varsani (2 shared papers)
- Journals
- Blood (4 papers)Pediatric Rheumatology (3 papers)Annals of the Rheumatic Diseases (3 papers)The Journal of Immunology (2 papers)Pharmaceuticals (2 papers)
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Mark Klein
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 106
- Immunology 657
- Hematology 256
- Rheumatology 142
- Oncology 201
- Speech and Hearing 48
Countries citing papers authored by Mark Klein
This map shows the geographic impact of Mark Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Klein more than expected).
Fields of papers citing papers by Mark Klein
This network shows the impact of papers produced by Mark Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Klein. The network helps show where Mark Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 307 | |
| 2 | 2005 | 181 | |
| 3 | 2011 | 119 | |
| 4 | 2012 | 67 | |
| 5 | 2007 | 63 | |
| 6 | 2006 | 48 | |
| 7 | 2017 | 46 | |
| 8 | 1997 | 45 | |
| 9 | 2008 | 32 | |
| 10 | 2014 | 28 | |
| 11 | 2022 | 28 | |
| 12 | 2013 | 27 | |
| 13 | 2010 | 25 | |
| 14 | 1976 | 25 | |
| 15 | 2012 | 24 | |
| 16 | 2011 | 22 | |
| 17 | 2023 | 17 | |
| 18 | 2015 | 17 | |
| 19 | 2021 | 16 | |
| 20 | Targeting cyclin D1 in non-small cell lung cancer and mesothelioma cells by antisense oligonucleotides. | 2011 | 15 |
About Mark Klein
Mark Klein is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Hematology, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (10 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Cancer-related Molecular Pathways (6 papers), Immunotherapy and Immune Responses (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Research and Treatments (3 papers) and Chemical Synthesis and Analysis (3 papers). The work is most often cited by research in Immunology (657 citations), Hematology (256 citations), Rheumatology (142 citations), Oncology (201 citations) and Speech and Hearing (48 citations). Mark Klein has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Berent J. Prakken, Wietse Kuis, Wilco de Jager, Sebastiaan J. Vastert, Salvatore Albani, Lucy R. Wedderburn, Nico Wulffraat, Hemlata Varsani, Ger T. Rijkers and Francesca Giannoni. Their work appears in journals such as Blood, Pediatric Rheumatology, Annals of the Rheumatic Diseases, The Journal of Immunology and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.